The investigation of paternal-effect lethal mutations in C. elegans

线虫父系效应致死突变的研究

基本信息

项目摘要

DNA topoisomerases are enzymes that play a crucial role in chromosome fidelity by disentangling topological problems that arise in double stranded DNA. This enzyme has primarily been studied in mitosis. However, one side effect of topoisomerase II inhibitors is both female and male infertility indicating that it also has functions in the meiotic cell cycle. The exact role that topoisomerase II plays during meiosis is unknown. Using a combination of classical genetics and cell biology, we found that top-2(it7ts) males produce dead embryos, even when fertilizing wild-type oocytes. Characterization of early embryonic events indicates that fertilization is successful and sperm components are transmitted to the embryo. However, sperm chromatin is not detected in these fertilized embryos. Examination of top-2(it7ts) spermatogenic germ lines reveals that the sperm DNA fails to segregate properly during the meiotic divisions. Chromatin bridges form during anaphase I and the chromatin is removed from developing spermatids creating anucleate sperm. These anucleate sperm are nonetheless capable of fertilization; early embryonic events appear normal but embryos arrest around the 200-cell stage. Type II DNA topoisomerases have well known roles in DNA replication and chromosome segregation in the mitotic cell cycle of yeast and bacteria. To determine if, similar to other organisms, C. elegans top-2 also plays a role in mitosis, we examined the proliferative zone of top-2(it7ts) males and hermaphrodites where germ cells undergo mitotic proliferation prior to entering meiosis. We found that hermaphrodite and male germ lines have enlarged mitotic germ cells (indicative of an S-phase arrest). In addition, a top-2 non-conditional deletion allele fails to proliferate a germ line. These two results suggest that top-2 has a mitotic function in the proliferative region of the germ line. Given the known enzymatic role of topoisomerase II in disentangling topological problems that arise in double-stranded DNA, we reasoned that TOP-2 might solve topological problems that arise during meiotic crossover recombination. top-2(it7ts) chromosome segregation defects observed during anaphase I are not due to residual entanglements incurred during meiotic DNA replication and are not a consequence of recombination defects. Finally, we tagged TOP-2 with a FLAG epitope by CRISPR/Cas9 gene editing (TOP-2::3XFLAG) to determine TOP-2 localization in the germ lines of hermaphrodites and males. We found that TOP-2 associates with chromosomes in meiotic prophase and that chromosome association is disrupted in the germ lines of top-2(it7ts) mutants. In the future, we aim to use TOP-2::3XFLAG to discover internal phosphorylation and SUMOylation sites: potential post-translational modifications required for TOP-2 regulation. We also are conducting a suppressor screen to identify mutants that restore viability and chromosome segregation to the top-2 mutant.
DNA 拓扑异构酶是通过解决双链 DNA 中出现的拓扑问题在染色体保真度中发挥关键作用的酶。这种酶主要在有丝分裂中进行研究。然而,拓扑异构酶 II 抑制剂的副作用之一是导致女性和男性不育,表明它在减数分裂细胞周期中也具有功能。拓扑异构酶 II 在减数分裂过程中发挥的确切作用尚不清楚。结合经典遗传学和细胞生物学,我们发现 top-2(it7ts) 雄性即使在使野生型卵母细胞受精时也会产生死亡胚胎。早期胚胎事件的表征表明受精成功并且精子成分被传递到胚胎。然而,在这些受精胚胎中未检测到精子染色质。对 top-2(it7ts) 生精生殖系的检查表明,精子 DNA 在减数分裂期间未能正确分离。染色质桥在后期 I 期间形成,染色质从发育中的精子细胞中去除,形成无核精子。这些无核精子仍然能够受精。早期胚胎事件看起来正常,但胚胎在 200 细胞阶段左右停滞。 II 型 DNA 拓扑异构酶在酵母和细菌有丝分裂细胞周期中的 DNA 复制和染色体分离中具有众所周知的作用。为了确定与其他生物类似,秀丽隐杆线虫top-2是否也在有丝分裂中发挥作用,我们检查了top-2(it7ts)雄性和雌雄同体的增殖区,其中生殖细胞在进入减数分裂之前经历有丝分裂增殖。我们发现雌雄同体和雄性生殖细胞有丝分裂生殖细胞增大(表明 S 期停滞)。此外,top-2 非条件删除等位基因无法增殖种系。这两个结果表明top-2在种系的增殖区域具有有丝分裂功能。 鉴于拓扑异构酶 II 在解开双链 DNA 中出现的拓扑问题中已知的酶作用,我们推断 TOP-2 可能会解决减数分裂交叉重组过程中出现的拓扑问题。在后期 I 期间观察到的 top-2(it7ts) 染色体分离缺陷不是由于减数分裂 DNA 复制过程中产生的残留缠结,也不是重组缺陷的结果。 最后,我们通过 CRISPR/Cas9 基因编辑 (TOP-2::3XFLAG) 为 TOP-2 标记 FLAG 表位,以确定 TOP-2 在雌雄同体和雄性种系中的定位。我们发现 TOP-2 在减数分裂前期与染色体结合,并且在 top-2(it7ts) 突变体的种系中染色体结合被破坏。未来,我们的目标是使用 TOP-2::3XFLAG 来发现内部磷酸化和 SUMOylation 位点:TOP-2 调节所需的潜在翻译后修饰。我们还正在进行抑制子筛选,以鉴定能够恢复 top-2 突变体的活力和染色体分离的突变体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andy Golden其他文献

Andy Golden的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andy Golden', 18)}}的其他基金

The investigation of paternal-effect lethal mutations in C. elegans
线虫父系效应致死突变的研究
  • 批准号:
    9565922
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
The role of SPE-11 in C. elegans egg activation
SPE-11 在秀丽隐杆线虫卵激活中的作用
  • 批准号:
    9148884
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
Cell Cycle Regulation In C. elegans
线虫的细胞周期调控
  • 批准号:
    8349664
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
Cell Cycle Regulation In C. elegans
线虫的细胞周期调控
  • 批准号:
    8553386
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
The role of VRK-1 during the meiotic divisions of C. elegans embryos
VRK-1 在秀丽隐杆线虫胚胎减数分裂中的作用
  • 批准号:
    7593449
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
The Investigation of disease causing genes in C. elegans
线虫致病基因的研究
  • 批准号:
    10706086
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
The Investigation of disease causing genes in C. elegans
线虫致病基因的研究
  • 批准号:
    9356216
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
The role of VRK-1 during the meiotic divisions of C. elegans embryos
VRK-1 在秀丽隐杆线虫胚胎减数分裂中的作用
  • 批准号:
    7967206
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
The role of SPE-11 in C. elegans egg activation
SPE-11 在秀丽隐杆线虫卵激活中的作用
  • 批准号:
    7734295
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:
The role of SPE-11 in C. elegans egg activation
SPE-11 在秀丽隐杆线虫卵激活中的作用
  • 批准号:
    8148901
  • 财政年份:
  • 资助金额:
    $ 26.68万
  • 项目类别:

相似国自然基金

等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
  • 批准号:
    32370714
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
  • 批准号:
    82300353
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
  • 批准号:
    82302575
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
  • 批准号:
    32302535
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
玉米穗行数QTL克隆及优异等位基因型鉴定
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

A high-throughput screen for inhibitors of Plk1-interacting checkpoint helicase (PICH)
Plk1 相互作用检查点解旋酶 (PICH) 抑制剂的高通量筛选
  • 批准号:
    10356280
  • 财政年份:
    2022
  • 资助金额:
    $ 26.68万
  • 项目类别:
A high-throughput screen for inhibitors of Plk1-interacting checkpoint helicase (PICH)
Plk1 相互作用检查点解旋酶 (PICH) 抑制剂的高通量筛选
  • 批准号:
    10557106
  • 财政年份:
    2022
  • 资助金额:
    $ 26.68万
  • 项目类别:
The role of dTopors in Drosophila male meiosis
dTopors 在果蝇雄性减数分裂中的作用
  • 批准号:
    10439122
  • 财政年份:
    2022
  • 资助金额:
    $ 26.68万
  • 项目类别:
Mitotic Checkpoint Regulators in Insulin Signaling
胰岛素信号传导中的有丝分裂检查点调节剂
  • 批准号:
    9980928
  • 财政年份:
    2017
  • 资助金额:
    $ 26.68万
  • 项目类别:
Deciphering How Esco2 Loss Acts as a Penetrance Modifier
解读 Esco2 损失如何作为外显率调节剂
  • 批准号:
    9888342
  • 财政年份:
    2017
  • 资助金额:
    $ 26.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了